Sribs Biotechniqs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-06-2024
- Paid Up Capital ₹ 0.10 M
as on 15-06-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.90 Cr
as on 15-06-2024
- Revenue -28.54%
(FY 2023)
- Profit -52.52%
(FY 2023)
- Ebitda -10.48%
(FY 2023)
- Net Worth 5.88%
(FY 2023)
- Total Assets 0.22%
(FY 2023)
About Sribs Biotechniqs
The Corporate was formerly known as Sribs Biotekno India Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.90 Cr.
Srilakshmi Polukonda and Sudhakar Polukonda serve as directors at the Company.
- CIN/LLPIN
U74900MH2013PTC247354
- Company No.
247354
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sribs Biotechniqs Private Limited offer?
Sribs Biotechniqs Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Fish Foods, Animal Feed Supplement, Feed Supplement, Industrial Chemicals & Supplies, Disinfectant Chemicals, Oxygen & Nitrogen Gas Plant, Oxygen Plant and Generator, Fertilizers and Soil Additives, Bio Fertilizers.
Who are the key members and board of directors at Sribs Biotechniqs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srilakshmi Polukonda  | Director | 22-Aug-2013 | Current |
| Sudhakar Polukonda | Director | 22-Aug-2013 | Current |
Financial Performance of Sribs Biotechniqs.
Sribs Biotechniqs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.54% decrease. The company also saw a substantial fall in profitability, with a 52.52% decrease in profit. The company's net worth moved up by a moderate rise of 5.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sribs Biotechniqs?
In 2023, Sribs Biotechniqs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maziq Farm Technologies Private LimitedActive 6 years 7 monthsSudhakar Polukonda is a mutual person
Jens Enviro Technologien Private LimitedActive 8 years 10 monthsSrilakshmi Polukonda and Sudhakar Polukonda are mutual person
East Shore Seafood Exports Private LimitedActive 4 years 4 monthsSudhakar Polukonda is a mutual person
- Serene Envirotech Solutions Private LimitedActive 4 years 4 months
Sudhakar Polukonda is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Mar 2022 | ₹1.34 M | Open |
Others Creation Date: 07 Sep 2020 | ₹2.69 M | Open |
Others Creation Date: 27 Feb 2018 | ₹1.50 Cr | Open |
How Many Employees Work at Sribs Biotechniqs?
Sribs Biotechniqs has a workforce of 23 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sribs Biotechniqs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sribs Biotechniqs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
